On October 5, Geoffrey Kaiser will participate in a Practising Law Institute (PLI) Enforcement Trends panel at the Institute’s Life Sciences conference. The program, entitled, “Life Sciences 2017: Navigating Legal Challenges in the Drug and Device Industries,” will be held in New York City.

For information and registration, click here.

Brian Bank has been appointed Chair of the Employment and Labor Litigation Committee of the American Bar Association’s Tort Trial and Insurance Practice Section.

Marc Ullman was quoted in Natural Products Insider’s article: “Hi-Tech Files Appeal in DMAA Fight with FDA,” which discusses Hi-Tech Pharmaceuticals Inc.’s quarrel with the federal government regarding the legality of the supplement DMAA, or 1,3-dimethylamylamine.

To read the article, click here.

Marc Ullman was quoted in a July 20, 2017 article entitled, “Executive Sold DMAA Supplements, Sentenced to Prison.” The story centers on the president of a dietary supplement company who was sentenced to an 18-month prison term for failing to disclose the presence the amphetamine derivative DMAA on the product labeling for his company’s supplements.

On June 26, Steven Shapiro will speak at the Dietary Supplements conference, a collaboration between the American Conference Institute and the Council for Responsible Nutrition. He will participate on a panel entitled, “FDA Roundup: Rulemaking and Other Activity Impacting the Dietary Supplement Industry,” where he will discuss the new Generally Recognized as Safe (GRAS) Rule and

Rivkin Radler, one of the Northeast’s leading law firms with three offices and more than 165 attorneys, is merging with the long-time Albany-based law firm of Iseman, Cunningham, Riester and Hyde (ICRH), with offices in Albany and Poughkeepsie, effective July 1, 2017. The firm will be known as Rivkin Radler and will feature one of

Marc Ullman was quoted in an article entitled, “How Will Donald Trump Affect Global Ingredient Sourcing?,” which was published in the April 2017 issue of Nutritional Outlook.

Click here to read the article.

Steven Shapiro authored an article for the April 2017 issue of Nutrition Industry Executive.  The article presents a case study in the enforcement of laws prohibiting false and deceptive advertising in connection with the marketing of nutritional supplements.

Click here to read the article.

Marc Ullman was quoted in an article entitled, “FDA Prevails Over Hi-Tech On DMAA, But Ruling Could Open Door On Synthetic Botanicals,” which was published in the April 2017 issue of NUTRA ingredients-usa.com.

Click here to read the article.

Marc Ullman and a panel of industry lawyers will present a webinar entitled, “Ensuring Your Dietary Supplement Claims are Truthful, Substantiated and Will Help Sell Your Product.”

The Federal Trade Commission (FTC) enforces against false, misleading and deceptive advertising. Claims can be misleading if they are not substantiated. Testimonials and social media can trip you